Carol B. Fox

1.9k total citations
19 papers, 695 citations indexed

About

Carol B. Fox is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Carol B. Fox has authored 19 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Carol B. Fox's work include Receptor Mechanisms and Signaling (7 papers), Synthesis and Biological Evaluation (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Carol B. Fox is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Synthesis and Biological Evaluation (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Carol B. Fox collaborates with scholars based in United States. Carol B. Fox's co-authors include Lorraine A. Lebel, B. Kenneth Koe, B. L. CHENARD, Todd W. Butler, Anne W. Schmidt, John E. Macor, Mary Collins, Ismail A. Shalaby, Leslie K. Chambers and J. Bordner and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Biochemical Pharmacology.

In The Last Decade

Carol B. Fox

19 papers receiving 666 citations

Peers

Countries citing papers authored by Carol B. Fox

Since Specialization

Citations

This map shows the geographic impact of Carol B. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol B. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol B. Fox more than expected).

Fields of papers citing papers by Carol B. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol B. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol B. Fox. The network helps show where Carol B. Fox may publish in the future.

Co-authorship network of co-authors of Carol B. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Carol B. Fox. A scholar is included among the top collaborators of Carol B. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol B. Fox. Carol B. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A 2009 ·Neuropharmacology ·Christine A. Strick, Larry C. James, Carol B. Fox, Thomas Seeger, Frank S. Menniti, Christopher J. Schmidt	40
2	Megestrol Acetate and Mirtazapine for the Treatment of Unplanned Weight Loss in the Elderly 2009 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Carol B. Fox, (unknown), (unknown), (unknown)	21
3	Low efficacy partial agonists of the α4β2 nicotinic acetylcholine receptor (nAChR). Does functional efficacy govern in vivo response? 2009 ·Biochemical Pharmacology ·Jotham W. Coe, Paige R. Brooks, Michael Wirtz, Michael G. Vetelino, Eric P. Arnold, Steven B. Sands, Thomas I. Davis, Lorraine A. Lebel, Carol B. Fox, Alka Shrikhande, Robert S. Mansbach, Leslie K. Chambers, (unknown), David W. Schulz, F. David Tingley, Brian T. O’Neill, Hans Rollema	1
4	Deconstructing cytisine: The syntheses of (±)-cyfusine and (±)-cyclopropylcyfusine, fused ring analogs of cytisine 2008 ·Bioorganic & Medicinal Chemistry Letters ·Daniel Yohannes, (unknown), Lorraine A. Lebel, Carol B. Fox, Brian T. O’Neill	17
5	Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors 2006 ·Journal of Medicinal Chemistry ·Thomas A. Chappie, John M. Humphrey, Martin P. Allen, Kimberly G. Estep, Carol B. Fox, Lorraine A. Lebel, Spiros Liras, Eric S. Marr, Frank S. Menniti, Jayvardhan Pandit, Christopher J. Schmidt, Meihua Tu, Robert D. Williams, (unknown)	93
6	In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine 2005 ·Bioorganic & Medicinal Chemistry Letters ·Jotham W. Coe, Michael G. Vetelino, (unknown), Michael Wirtz, Paige R. Brooks, Eric P. Arnold, Lorraine A. Lebel, Carol B. Fox, Steven B. Sands, Thomas I. Davis, David W. Schulz, Hans Rollema, F. David Tingley, Brian T. O’Neill	49
7	3,5-Bicyclic aryl piperidines: A novel class of α4β2 neuronal nicotinic receptor partial agonists for smoking cessation 2005 ·Bioorganic & Medicinal Chemistry Letters ·Jotham W. Coe, Paige R. Brooks, Michael Wirtz, (unknown), (unknown), Michael G. Vetelino, Eric P. Arnold, Lorraine A. Lebel, Carol B. Fox, F. David Tingley, David W. Schulz, Thomas I. Davis, Steven B. Sands, Robert S. Mansbach, Hans Rollema, Brian T. O’Neill	57
8	Molecular mechanisms for the putative antipsychotic activity of PDE10A inhibitors: PDE10A regulation of intracellular signaling in striatal medium spiny neurons in culture 2003 ·Schizophrenia Research ·Frank S. Menniti, Timothy M. Brown, Michael A. Collins, Carol B. Fox, Lida Kimmel, Robin J. Kleiman, Lorraine A. Lebel, A. M. Ryan, (unknown), Thomas Seeger, Alka Shrikhande, (unknown), (unknown)	3
9	(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses 1995 ·Journal of Medicinal Chemistry ·B. L. CHENARD, J. Bordner, Todd W. Butler, Leslie K. Chambers, Mary Collins, (unknown), (unknown), (unknown), Carol B. Fox	150
10	5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl] benzimidazole (CP-161,242): A potent, centrally active 5-HT1D receptor agonist and benzodiazepine partial agonist 1995 ·Bioorganic & Medicinal Chemistry Letters ·John E. Macor, David H.A. Blank, (unknown), Carol B. Fox, B. Kenneth Koe, Lorraine A. Lebel, Ronald J. Post, Anne W. Schmidt, David W. Schulz, Patricia A. Seymour	1
11	ChemInform Abstract: (1S,2S)‐1‐(4‐Hydroxyphenyl)‐2‐(4‐hydroxy‐4‐phenylpiperidino)‐1‐ propanol: A Potent New Neuroprotectant Which Blocks N‐Methyl‐D‐ aspartate Responses. 1995 ·ChemInform ·B. L. CHENARD, Jon Bordner, Todd W. Butler, Leslie K. Chambers, Mary Collins, (unknown), (unknown), (unknown), Carol B. Fox, E. Edward Mena, Frank S. Menniti, J.A. Nielsen, Martin J. Pagnozzi, K. Richter, (unknown), Ismail A. Shalaby, (unknown), William F. White	20
12	5-[(3-Nitropyrid-2-yl)amino]indoles: Novel Serotonin Agonists with Selectivity for the 5-HT1D Receptor. Variation of the C3 Substituent on the Indole Template Leads to Increased 5-HT1D Receptor Selectivity 1994 ·Journal of Medicinal Chemistry ·John E. Macor, (unknown), Carol B. Fox, Lorraine A. Lebel, Michael E. Newman, Ronald J. Post, Kevin Ryan, Anne W. Schmidt, David W. Schulz, B. Kenneth Koe	27
13	Dopamine uptake inhibitory activity of novel tryptamine 5‐HT₁ receptor ligands 1994 ·Drug Development Research ·Lorraine A. Lebel, (unknown), John E. Macor, Carol B. Fox, B. Kenneth Koe	13
14	Oxindole N-Methyl-D-Aspartate (NMDA) antagonists 1993 ·Bioorganic & Medicinal Chemistry Letters ·B. L. CHENARD, Todd W. Butler, Ismail A. Shalaby, (unknown), B. Kenneth Koe, Carol B. Fox	4
15	Characterization of [³H]CP‐96,501 as a Selective Radioligand for the Serotonin 5‐HT_1B Receptor: Binding Studies in Rat Brain Membranes 1992 ·Journal of Neurochemistry ·B. Kenneth Koe, Lorraine A. Lebel, Carol B. Fox, John E. Macor	20
16	Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin 1992 ·Journal of Medicinal Chemistry ·John E. Macor, (unknown), Carol B. Fox, (unknown), B. Kenneth Koe, Lorraine A. Lebel, Jean Morrone, Kevin Ryan, Anne W. Schmidt	14
17	1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors 1992 ·Journal of Medicinal Chemistry ·John E. Macor, Carol B. Fox, (unknown), B. Kenneth Koe, Lorraine A. Lebel, Stevin H. Zorn	19
18	Binding and uptake studies with [³H]CP‐93, 129, a radiolabeled selective 5‐HT_1B receptor ligand 1992 ·Drug Development Research ·B. Kenneth Koe, Lorraine A. Lebel, Carol B. Fox, John E. Macor	16
19	Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds 1991 ·Journal of Medicinal Chemistry ·B. L. CHENARD, Ismail A. Shalaby, B. Kenneth Koe, (unknown), Todd W. Butler, (unknown), Anne W. Schmidt, Carol B. Fox	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact